QMS vs compliance analysis
Qualio is the system of record for your quality processes — SOPs, training matrices, CAPA — and as of late 2025 it added Compliance Intelligence, which runs gap analysis against named frameworks like FDA QMSR, ISO 13485, and ICH Q10. Regfo works at a different altitude: it ingests your preclinical study reports and checks them against the specific ICH/FDA rules that gate an IND, returning each gap with the paragraph that triggered it. The two overlap less than it looks — Qualio centers on quality-system compliance, Regfo on drug/IND submission readiness.
Regfo
Answers "are my preclinical studies IND-ready?" with paragraph-level citations.
Qualio
Runs quality-system compliance plus framework-level gap analysis across GxP/device standards.
Pricing and decision window
Qualio does not publish prices — it is quote-only, and its pricing page notes an implementation fee applies to all plans. Third-party crowd-sourced data (RepVue) puts a typical deal around $24K/yr; treat that as an estimate, not an official figure. Regfo lives in the five-figure range ($4.8K–$12K/yr) with public, self-serve pricing. Many biotech teams use both — Regfo during the IND window, Qualio as the ongoing QMS once the company scales.
Regfo
Free ($0), Pro ($399/mo), Team ($999/mo). 20% off annual. No setup fees, no implementation contracts.
Qualio
Quote-only; implementation fee on all plans. Third-party estimate ~$24K/yr (RepVue).
Speed to first insight
Implementing a QMS is a months-long project by design — you have to migrate SOPs, configure approval flows, map training. Running Regfo on a study report is a 30-second operation. If the immediate question is "what is going to get me a refuse-to-file?" the 30-second answer wins the week.
Regfo
Gap report, with citations, on day one.
Qualio
Full QMS value emerges over the first 60–90 days.